Drawing for EXTELLIA THERAPEUTICS

USPTO serial 86864974

EXTELLIA THERAPEUTICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LEIPZIG, MARC J
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EXTELLIA THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jonathan M. Gelchinsky

Jonathan M. Gelchinsky Pierce Atwood LLP254 Commercial StreetPortland, ME 04101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells based on gene, genome and cellular editing, modulation, modification, engineering, regulation, and repair therapy for use in human therapeutics; diagnostic preparations for medical purposes based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapyACTIVE—
042Scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; Design of bioinformatic algorithms and models for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 26, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 26, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 1, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 31, 2018EX5GSOU EXTENSION 5 GRANTED—
Dec 31, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 14, 2018EXT5SOU EXTENSION 5 FILED—
Dec 14, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 23, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 22, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 20, 2018EX4GSOU EXTENSION 4 GRANTED—
Jun 20, 2018EXT4SOU EXTENSION 4 FILED—
Jun 20, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 4, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 2, 2018EX3GSOU EXTENSION 3 GRANTED—
Jan 2, 2018EXT3SOU EXTENSION 3 FILED—
Jan 2, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 16, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 18, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 14, 2017EX2GSOU EXTENSION 2 GRANTED—
Jul 14, 2017EXT2SOU EXTENSION 2 FILED—
Jul 14, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 25, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 23, 2017EX1GSOU EXTENSION 1 GRANTED—
Jan 23, 2017EXT1SOU EXTENSION 1 FILED—
Jan 23, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 26, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 31, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 31, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 11, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 19, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Apr 19, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 19, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 19, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 19, 2016DOCKASSIGNED TO EXAMINER—
Jan 13, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 12, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 7, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance